Jubilant Pharmova Limited (NSE: JUBLPHARMA)
India
· Delayed Price · Currency is INR 1,138.50
+8.15 (0.72%)
Nov 22, 2024, 3:30 PM IST
Jubilant Pharmova Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 22, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 180,710 | 90,432 | 44,418 | 61,740 | 108,375 | 39,635 | Upgrade
|
| Market Cap Growth | 163.70% | 103.60% | -28.06% | -43.03% | 173.43% | -61.69% | Upgrade
|
| Enterprise Value | 200,605 | 117,283 | 70,881 | 82,624 | 136,642 | 69,995 | Upgrade
|
| Last Close Price | 1138.50 | 566.61 | 273.82 | 375.70 | 654.27 | 239.38 | Upgrade
|
| PE Ratio | - | 117.29 | - | 14.92 | 12.97 | 4.41 | Upgrade
|
| PS Ratio | 2.64 | 1.35 | 0.71 | 1.01 | 1.78 | 0.66 | Upgrade
|
| PB Ratio | 3.08 | 1.67 | 0.82 | 1.16 | 2.29 | 0.71 | Upgrade
|
| P/TBV Ratio | 7.64 | 4.69 | 2.20 | 2.87 | 5.98 | 1.42 | Upgrade
|
| P/FCF Ratio | - | 122.87 | - | 25.99 | 8.62 | 4.09 | Upgrade
|
| P/OCF Ratio | 23.76 | 9.31 | 6.72 | 7.37 | 6.07 | 2.57 | Upgrade
|
| EV/Sales Ratio | 2.90 | 1.75 | 1.13 | 1.35 | 2.24 | 1.17 | Upgrade
|
| EV/EBITDA Ratio | 19.59 | 14.78 | 10.97 | 7.75 | 9.31 | 4.52 | Upgrade
|
| EV/EBIT Ratio | 28.65 | 22.42 | 18.91 | 9.84 | 11.94 | 5.65 | Upgrade
|
| EV/FCF Ratio | -73.11 | 159.35 | - | 34.78 | 10.87 | 7.22 | Upgrade
|
| Debt / Equity Ratio | 0.52 | 0.68 | 0.68 | 0.60 | 0.60 | 0.86 | Upgrade
|
| Debt / EBITDA Ratio | 3.14 | 4.31 | 5.18 | 2.82 | 1.93 | 3.11 | Upgrade
|
| Debt / FCF Ratio | - | 49.78 | - | 13.44 | 2.25 | 4.96 | Upgrade
|
| Asset Turnover | 0.59 | 0.59 | 0.59 | 0.65 | 0.57 | 0.50 | Upgrade
|
| Inventory Turnover | 1.92 | 1.73 | 1.54 | 1.23 | 1.02 | 0.87 | Upgrade
|
| Quick Ratio | 0.98 | 1.18 | 1.26 | 1.34 | 1.64 | 1.16 | Upgrade
|
| Current Ratio | 1.80 | 2.05 | 2.12 | 2.20 | 2.82 | 1.92 | Upgrade
|
| Return on Equity (ROE) | 10.40% | 1.34% | -1.21% | 8.21% | 11.09% | 13.02% | Upgrade
|
| Return on Assets (ROA) | 3.52% | 2.88% | 2.22% | 5.55% | 6.67% | 6.45% | Upgrade
|
| Return on Capital (ROIC) | 4.54% | 3.60% | 2.67% | 6.53% | 7.95% | 7.72% | Upgrade
|
| Earnings Yield | 3.28% | 0.85% | -1.37% | 6.70% | 7.71% | 22.66% | Upgrade
|
| FCF Yield | -1.50% | 0.81% | -3.46% | 3.85% | 11.60% | 24.44% | Upgrade
|
| Dividend Yield | 0.00% | 0.88% | 1.83% | 1.33% | 0.76% | 2.09% | Upgrade
|
| Payout Ratio | 13.42% | 103.50% | - | 19.34% | 0.18% | 16.84% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | 0.18% | 0.02% | 0.06% | 0.01% | -2.19% | Upgrade
|
| Total Shareholder Return | 0.03% | 1.07% | 1.84% | 1.39% | 0.77% | -0.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.